Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Neurologic Stem Cell Treatment Study [NA]
Clinical trial update shows a neurologic stem cell treatment study sponsored by MD Stem Cells is currently recruiting. The study lists a wid…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease [NA]
A clinical trial at Oregon Health and Science University is recruiting to evaluate balance tele-rehabilitation in individuals with Parkinson…
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Parkinson's Disease
A pilot study from ProgenaBiome investigating the role of gut flora in Parkinson's disease has been withdrawn.
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Smartshoes for Freezing of Gait in Parkinson's Disease [NA]
Clinical trial update for Smartshoes aimed at reducing freezing of gait in Parkinson's disease; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Effect of Exercise, Endocannabinoids and Ketones on Cerebral Metabolism in a Cognitive Disorders Population [NA]
A completed clinical trial studied the effects of exercise, endocannabinoids, and ketones on cerebral metabolism in individuals with cogniti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands [NA]
The Slow-SPEED-NL clinical trial in the Netherlands is currently recruiting to evaluate exercise dosage as an intervention for slowing early…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage [NA]
A clinical trial update for Slow-SPEED, a study exploring exercise dosage to slow progression in early Parkinson's disease and prodromal sta…
-
EMA approval · 2025-06-02EMA Authorised: Corbilta (previously Levodopa/Carbidopa/Entacapone Sandoz) (levodopa;carbidopa;entacapone) — Orion Corporation
EU marketing authorisation granted for Corbilta, a fixed-dose combination of levodopa, carbidopa and entacapone, for Parkinson's disease, to…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Amped-PD: Amplifying Physical Activity Through Music in Parkinson Disease [NA]
Update on the Amped-PD trial evaluating a music-based intervention to increase physical activity in Parkinson disease; the study is complete…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops® Relative to INBRIJA® [Phase 1]
A Phase 1 pilot bioavailability study has been completed. It compares levodopa delivered via the Levodopa Cyclops device to INBRIJA (levodop…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Imaging Core Aim 2, and Udall Project 2 Aim 2 [NA]
A University of Minnesota–led clinical trial focusing on imaging core Aim 2 and Udall Project 2 Aim 2 for Parkinson disease is currently rec…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: VC/VS for Apathy in PD [NA]
A clinical trial is evaluating VC/VS for apathy in Parkinson disease, and the study is currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: The GBA Multimodal Study in Parkinson's Disease
The GBA Multimodal Study in Parkinson's Disease is an ongoing clinical trial investigating GBA gene mutations in Parkinson's disease and is …
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Mechanism and Application of DBS in the Treatment of PD [NA]
An ongoing clinical trial is investigating the mechanisms and clinical applications of deep brain stimulation for Parkinson's disease, curre…
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Monocentric, Prospective Study to Assess the Pharmacokinetic Profile of Continuous and Diurnal Subcutaneous Apomorphine Infusion in Patients With Parkinson's Disease [Phase 4]
This Phase 4 study evaluated the pharmacokinetic profile of continuous and diurnal subcutaneous apomorphine infusions in Parkinson's disease…
-
CLINICAL_TRIALS research · 2025-05-30Clinical Trial Update: Combined STN and NBM Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's Disease [NA]
This clinical trial is evaluating combined subthalamic nucleus and nucleus basalis of Meynert deep brain stimulation for mild cognitive impa…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Correlation of STN-DBS Induced Visuospatial Changes and Freezing of Gait [NA]
A study investigating the correlation between subthalamic nucleus deep brain stimulation–induced visuospatial changes and freezing of gait i…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Enhancement of Quality of Work And Life [NA]
ClinicalTrials.gov update for the study 'Enhancement of Quality of Work And Life' sponsored by Radboud University Medical Center, currently …
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Cerebellar Transcranial Alternating Current Stimulation (tACS) to Modulate Parkinson's Disease Tremor [NA]
Clinical trial is currently recruiting to evaluate cerebellar transcranial alternating current stimulation (tACS) to modulate tremor in Park…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: An Observational Study of Subcutaneous Infusion of ABBV-951 to Assess Change in Disease Activity and Adverse Events In Adult Japanese Participants With Advanced Parkinson's Disease
An observational clinical trial evaluating subcutaneous infusion of ABBV-951 in adult Japanese participants with advanced Parkinson's diseas…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Mass Balance Recovery and Metabolite Identification of Carbon-14 BIA 28-6156 [Phase 1]
Phase 1 study reporting mass balance recovery and metabolite identification for the carbon-14 labeled compound BIA 28-6156 in participants w…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Burst-Type Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease [NA]
This document reports on a terminated clinical trial evaluating burst-type deep brain stimulation of the subthalamic nucleus for Parkinson d…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Evaluation of Impaired Mobility in Chronic Illness Constitution of a Cohort [NA]
A ClinicalTrials.gov listing describes a recruiting study sponsored by University Hospital, Clermont-Ferrand, evaluating impaired mobility i…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Molecular Mediators of Physical Exercise and Carnosine Induced Effects in Patients With Preclinical and Early Stage Neurodegenerative Disease [NA]
Completed clinical trial evaluating the molecular mediators of physical exercise and carnosine-induced effects in preclinical and early-stag…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Mental Health Support for People Affected by Parkinson's [NA]
An ongoing clinical trial at University College London is enrolling by invitation to study mental health support for people affected by Park…